130 related articles for article (PubMed ID: 6654176)
1. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors.
Chen SS; Lee L
Gynecol Oncol; 1983 Dec; 16(3):319-25. PubMed ID: 6654176
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
3. Extrauterine spread in endometrial carcinoma clinically confined to the uterus.
Chen SS
Gynecol Oncol; 1985 May; 21(1):23-31. PubMed ID: 3988126
[TBL] [Abstract][Full Text] [Related]
4. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.
Chuang L; Burke TW; Tornos C; Marino BD; Mitchell MF; Tortolero-Luna G; Levenback C; Morris M; Gershenson DM
Gynecol Oncol; 1995 Aug; 58(2):189-93. PubMed ID: 7622103
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
8. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus.
Chen SS
Gynecol Oncol; 1989 Feb; 32(2):215-7. PubMed ID: 2910783
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.
Doering DL; Barnhill DR; Weiser EB; Burke TW; Woodward JE; Park RC
Obstet Gynecol; 1989 Dec; 74(6):930-3. PubMed ID: 2586959
[TBL] [Abstract][Full Text] [Related]
10. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
[TBL] [Abstract][Full Text] [Related]
11. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
13. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.
Boronow RC; Morrow CP; Creasman WT; Disaia PJ; Silverberg SG; Miller A; Blessing JA
Obstet Gynecol; 1984 Jun; 63(6):825-32. PubMed ID: 6728365
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I.
Candiani GB; Belloni C; Maggi R; Colombo G; Frigoli A; Carinelli SG
Gynecol Oncol; 1990 Apr; 37(1):6-8. PubMed ID: 2323614
[TBL] [Abstract][Full Text] [Related]
15. Endometrial adenocarcinoma: therapeutic impact of preoperative histopathologic examination of endometrial tissue.
Oakley G; Nahhas WA
Eur J Gynaecol Oncol; 1989; 10(4):255-60. PubMed ID: 2776782
[TBL] [Abstract][Full Text] [Related]
16. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
17. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer: evaluation of spread and follow-up one hundred eighty-nine patients with Stage I or Stage II disease.
Burrell MO; Franklin EW; Powell JL
Am J Obstet Gynecol; 1982 Sep; 144(2):181-5. PubMed ID: 7114127
[TBL] [Abstract][Full Text] [Related]
20. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
